» Articles » PMID: 39651986

2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2024 Dec 9
PMID 39651986
Affiliations
Soon will be listed here.
Abstract

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

Citing Articles

The Role of the Planetary Diet in Managing Metabolic Syndrome and Cardiovascular Disease: A Narrative Review.

Muszalska A, Wiecanowska J, Michalowska J, Pastusiak-Zgolinska K, Polok I, Lompies K Nutrients. 2025; 17(5).

PMID: 40077732 PMC: 11901553. DOI: 10.3390/nu17050862.


Atherogenic index of plasma, high sensitivity C-reactive protein and incident diabetes among middle-aged and elderly adults in China: a national cohort study.

Wang T, Zhang M, Shi W, Li Y, Zhang T, Shi W Cardiovasc Diabetol. 2025; 24(1):103.

PMID: 40045300 PMC: 11883954. DOI: 10.1186/s12933-025-02653-4.


Brazilian guideline for screening and diagnosis of type 2 diabetes: a position statement from the Brazilian Diabetes Society.

Rodacki M, Zajdenverg L, da Silva Junior W, Giacaglia L, Negrato C, Cobas R Diabetol Metab Syndr. 2025; 17(1):78.

PMID: 40038723 PMC: 11881304. DOI: 10.1186/s13098-024-01572-w.


Association of Oxidative Stress Markers with Incident Hyperglycemia in Gestational Diabetes Mellitus in an Educational Intervention.

Ruiz-Martinez M, Gomez-Diaz R, Valdez Gonzalez A, Angeles Mejia S, Mondragon Gonzalez R, Diaz Flores M Nutrients. 2025; 17(4).

PMID: 40005008 PMC: 11858598. DOI: 10.3390/nu17040680.


Predictive role of gait parameters and MRI markers in assessing cognitive decline in CSVD patients.

Liu Y, Zhang L, Yang S, Liu R, Yi L, Liu M BMC Geriatr. 2025; 25(1):116.

PMID: 39979850 PMC: 11841008. DOI: 10.1186/s12877-025-05738-7.


References
1.
Herold K, Bundy B, Long S, Bluestone J, DiMeglio L, Dufort M . An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med. 2019; 381(7):603-613. PMC: 6776880. DOI: 10.1056/NEJMoa1902226. View

2.
Krischer J . The use of intermediate endpoints in the design of type 1 diabetes prevention trials. Diabetologia. 2013; 56(9):1919-24. PMC: 3743228. DOI: 10.1007/s00125-013-2960-7. View

3.
Crowther C, Hiller J, Moss J, McPhee A, Jeffries W, Robinson J . Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005; 352(24):2477-86. DOI: 10.1056/NEJMoa042973. View

4.
Scholtens D, Kuang A, Lowe L, Hamilton J, Lawrence J, Lebenthal Y . Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism. Diabetes Care. 2019; 42(3):381-392. PMC: 6385697. DOI: 10.2337/dc18-2021. View

5.
Jenssen T, Hartmann A . Emerging treatments for post-transplantation diabetes mellitus. Nat Rev Nephrol. 2015; 11(8):465-77. DOI: 10.1038/nrneph.2015.59. View